This article, co-authored by a patient affected by bilateral, recurrent, atypical optic neuritis, and clinicians, discusses the mental burden of living with uncertainty and the possibility of further sight loss, along with the side effects of treatment. The patient shares some of the challenges, coping strategies, and the value they found in creating and participating in a patient support group. The physicians consider whether current clinical measures adequately capture the outcomes that matter to patients and discuss the role for patient-reported outcome measures (PROMs). We identify technological advances that are lowering traditional barriers to the use of PROMs in research and routine clinical care and look towards new PROM instruments...
Although patients with acute optic neuritis (ON) recover high-contrast visual acuity (HCVA) to 20/40...
In optic neuritis (ON) inflammation precedes onset of demyelination and axonal loss. The anti-inflam...
AIM AND OBJECTIVES: To study the visual function, response to treatment and visual outcome in patie...
PURPOSE OF REVIEW: This article discusses the advantages and pitfalls of testing neuroprotective tre...
This commentary article is co-authored by an adult patient with X-linked retinoschisis and two ophth...
© 2010 Matti et al; licensee BioMed Central Ltd. This is an Open Access article distributed under...
Purpose To identify and comprehensively evaluate studies capturing the experience of individuals af...
Introduction: An association between facial trauma and blindness has long been recognized,1 but it w...
Objective: To identify differences in demographics, clinical characteristics, diagnostic studies and...
Previously, optic neuritis was thought to be typical, i.e. idiopathic or multiple sclerosis (MS) rel...
Acute optic neuritis Unmet clinical needs and model for new therapies Idiopathic demyelinating optic...
Optic neuritis (ON) is the presence of an acute inflammation of the optic nerve that results in pai...
Background: Short-term outcomes of optic neuritis (ON) have been well characterized. Limited data ex...
Background: Optic neuritis is a demyelinating inflammatory disease of the optic nerve that typically...
John H Pula,1 Christopher J MacDonald21Division of Neuro-ophthalmology, University of Illinois Colle...
Although patients with acute optic neuritis (ON) recover high-contrast visual acuity (HCVA) to 20/40...
In optic neuritis (ON) inflammation precedes onset of demyelination and axonal loss. The anti-inflam...
AIM AND OBJECTIVES: To study the visual function, response to treatment and visual outcome in patie...
PURPOSE OF REVIEW: This article discusses the advantages and pitfalls of testing neuroprotective tre...
This commentary article is co-authored by an adult patient with X-linked retinoschisis and two ophth...
© 2010 Matti et al; licensee BioMed Central Ltd. This is an Open Access article distributed under...
Purpose To identify and comprehensively evaluate studies capturing the experience of individuals af...
Introduction: An association between facial trauma and blindness has long been recognized,1 but it w...
Objective: To identify differences in demographics, clinical characteristics, diagnostic studies and...
Previously, optic neuritis was thought to be typical, i.e. idiopathic or multiple sclerosis (MS) rel...
Acute optic neuritis Unmet clinical needs and model for new therapies Idiopathic demyelinating optic...
Optic neuritis (ON) is the presence of an acute inflammation of the optic nerve that results in pai...
Background: Short-term outcomes of optic neuritis (ON) have been well characterized. Limited data ex...
Background: Optic neuritis is a demyelinating inflammatory disease of the optic nerve that typically...
John H Pula,1 Christopher J MacDonald21Division of Neuro-ophthalmology, University of Illinois Colle...
Although patients with acute optic neuritis (ON) recover high-contrast visual acuity (HCVA) to 20/40...
In optic neuritis (ON) inflammation precedes onset of demyelination and axonal loss. The anti-inflam...
AIM AND OBJECTIVES: To study the visual function, response to treatment and visual outcome in patie...